{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:28:02Z","timestamp":1786336082456,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/s12884-026-09344-2","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:04:57Z","timestamp":1780448697000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Maternal serum adropin as a potential biomarker for placenta accreta spectrum: a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9786-0872","authenticated-orcid":false,"given":"Seray","family":"S\u0131rk\u0131nt\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9381-4892","authenticated-orcid":false,"given":"Gulsum","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8307-9153","authenticated-orcid":false,"given":"Sule G\u00fcl","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6320-337X","authenticated-orcid":false,"given":"Merve Vay","family":"Bedir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"3","key":"9344_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/jmf.13.3.175.190","volume":"13","author":"A Faiz","year":"2003","unstructured":"Faiz A, Ananth C. Etiology and risk factors for placenta previa: an overview and meta-analysis of observational studies. J maternal-fetal neonatal Med. 2003;13(3):175\u201390.","journal-title":"J maternal-fetal neonatal Med"},{"key":"9344_CR2","unstructured":"Brennan K. Placental pathology: A review of placenta previa, placental abruption and placenta accreta. Update Anaesth. 2019;34."},{"issue":"4","key":"9344_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.17085\/apm.20076","volume":"15","author":"H-S Park","year":"2020","unstructured":"Park H-S, Cho H-S. Management of massive hemorrhage in pregnant women with placenta previa. Anesth Pain Med. 2020;15(4):409\u201316.","journal-title":"Anesth Pain Med"},{"issue":"10","key":"9344_CR4","doi-asserted-by":"publisher","first-page":"e0276153","DOI":"10.1371\/journal.pone.0276153","volume":"17","author":"W Watthanasathitnukun","year":"2022","unstructured":"Watthanasathitnukun W, Pranpanus S, Petpichetchian C. Two-dimensional ultrasound signs as predictive markers of massive peri-operative blood loss in placenta previa suspicious for placenta accreta spectrum (PAS) disorder. PLoS ONE. 2022;17(10):e0276153.","journal-title":"PLoS ONE"},{"issue":"11suppl1","key":"9344_CR5","first-page":"S185","volume":"122","author":"F Lovren","year":"2010","unstructured":"Lovren F, Pan Y, Quan A, Singh KK, Shukla PC, Gupta M, et al. Adropin is a novel regulator of endothelial function. Circulation. 2010;122(11suppl1):S185\u201392.","journal-title":"Circulation"},{"key":"9344_CR6","doi-asserted-by":"publisher","first-page":"561370","DOI":"10.3389\/fendo.2020.561370","volume":"11","author":"E Stelcer","year":"2020","unstructured":"Stelcer E, Milecka P, Komarowska H, Jopek K, Tyczewska M, Szyszka M, et al. Adropin stimulates proliferation and inhibits adrenocortical steroidogenesis in the human adrenal carcinoma (HAC15) cell line. Front Endocrinol. 2020;11:561370.","journal-title":"Front Endocrinol"},{"issue":"11","key":"9344_CR7","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1016\/j.ajem.2016.04.014","volume":"34","author":"B Gulen","year":"2016","unstructured":"Gulen B, Eken C, Kucukdagli OT, Serinken M, Kocyigit A, K\u0131l\u0131c E, et al. Adropin levels and target organ damage secondary to high blood pressure in the ED. Am J Emerg Med. 2016;34(11):2061\u20134.","journal-title":"Am J Emerg Med"},{"issue":"4","key":"9344_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1515\/jpm-2012-0227","volume":"41","author":"E Celik","year":"2013","unstructured":"Celik E, Yilmaz E, Celik O, Ulas M, Turkcuoglu I, Karaer A, et al. Maternal and fetal adropin levels in gestational diabetes mellitus. J Perinat Med. 2013;41(4):375\u201380.","journal-title":"J Perinat Med"},{"issue":"7","key":"9344_CR9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s40618-016-0453-5","volume":"39","author":"T Kume","year":"2016","unstructured":"Kume T, Calan M, Yilmaz O, Kocabas G, Yesil P, Temur M, et al. A possible connection between tumor necrosis factor alpha and adropin levels in polycystic ovary syndrome. J Endocrinol Investig. 2016;39(7):747\u201354.","journal-title":"J Endocrinol Investig"},{"issue":"5","key":"9344_CR10","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.rbmo.2021.01.020","volume":"42","author":"Z Ye","year":"2021","unstructured":"Ye Z, Zhang C, Zhao Y. Potential effects of adropin on systemic metabolic and hormonal abnormalities in polycystic ovary syndrome. Reprod Biomed Online. 2021;42(5):1007\u201314.","journal-title":"Reprod Biomed Online"},{"issue":"15","key":"9344_CR11","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.2169\/internalmedicine.50.5163","volume":"50","author":"W Lian","year":"2011","unstructured":"Lian W, Gu X, Qin Y, Zheng X. Elevated plasma levels of adropin in heart failure patients. Intern Med. 2011;50(15):1523\u20137.","journal-title":"Intern Med"},{"issue":"8","key":"9344_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1177\/00033197231183228","volume":"75","author":"E Karaca","year":"2024","unstructured":"Karaca E, Ercan CC, Akdemir C, Sivrikoz TS, Salmaslioglu A, Verit FF, et al. The evaluation of adropin and autotaxin as potential markers of endothelial dysfunction in preeclampsia. Angiology. 2024;75(8):779\u201385.","journal-title":"Angiology"},{"issue":"6","key":"9344_CR13","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1515\/jpm-2014-0353","volume":"44","author":"HI Aydin","year":"2016","unstructured":"Aydin HI, Eser A, Kaygusuz I, Yildirim S, Celik T, Gunduz S, et al. Adipokine, adropin and endothelin-1 levels in intrauterine growth restricted neonates and their mothers. J Perinat Med. 2016;44(6):669\u201376.","journal-title":"J Perinat Med"},{"issue":"9","key":"9344_CR14","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3109\/09513590.2015.1065480","volume":"31","author":"S Nergiz","year":"2015","unstructured":"Nergiz S, Altinkaya SO, Kurt \u00d6m\u00fcrl\u00fc \u0130, Yuksel H, K\u00fc\u00e7\u00fck M, Demircan Sezer S. Circulating adropin levels in patients with endometrium cancer. Gynecol Endocrinol. 2015;31(9):730\u20135.","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"9344_CR15","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/uog.13194","volume":"42","author":"F D\u2019Antonio","year":"2013","unstructured":"D\u2019Antonio F, Iacovella C, Bhide A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2013;42(5):509\u201317.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"9344_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/uog.13327","volume":"44","author":"F D\u2019antonio","year":"2014","unstructured":"D\u2019antonio F, Iacovella C, Palacios-Jaraquemada J, Bruno C, Manzoli L, Bhide A. Prenatal identification of invasive placentation using magnetic resonance imaging: systematic review and meta\u2010analysis. Ultrasound Obstet Gynecol. 2014;44(1):8\u201316.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"9344_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/uog.17417","volume":"49","author":"A Bhide","year":"2017","unstructured":"Bhide A, Sebire N, Abuhamad A, Acharya G, Silver R. Morbidly adherent placenta: the need for standardization. Ultrasound Obstet Gynecol. 2017;49(5):559\u201363.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"9344_CR18","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1515\/cclm-2013-0844","volume":"52","author":"L Wu","year":"2014","unstructured":"Wu L, Fang J, Chen L, Zhao Z, Luo Y, Lin C, et al. Low serum adropin is associated with coronary atherosclerosis in type 2 diabetic and non-diabetic patients. Clin Chem Lab Med. 2014;52(5):751\u20138.","journal-title":"Clin Chem Lab Med"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-09344-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09344-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09344-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T03:35:32Z","timestamp":1786332932000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-026-09344-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9344"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-09344-2","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This cross-sectional study was approved by the Ethics Committee of University of Health Sciences Adana City Training and Research Hospital (Date: 25.07.2024; Decision No: 79) and was conducted in accordance with the Declaration of Helsinki. All participants were informed about the purpose and procedures of the study before enrollment. Written informed consent was obtained from all participants.The study did not include any questionnaires. Clinical and laboratory data were collected as part of routine clinical evaluation, and all data were kept confidential.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"868"}}